Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids

European Journal of Endocrinology

Volumn 152, Issue 3, 2005, Pages 443-448

  Peracchi, Maddalena ^a   Gebbia, C ^a   Basilisco, G ^a   Quatrini, M ^a   Tarantino, C ^a   Vescarelli, C ^a   Massironi, S ^a   Conte, D ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; GASTRIN;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; CARCINOID; CELL DAMAGE; CELL HYPERPLASIA; CELL PROLIFERATION; CHRONIC GASTRITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; ENTEROCHROMAFFIN CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HISTOPATHOLOGY; HUMAN; HYPERGASTRINEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SENSITIVITY AND SPECIFICITY; STOMACH BIOPSY; STOMACH CANCER; VOLUNTEER;

AGED; AUTOIMMUNE DISEASES; CARCINOID TUMOR; CASE-CONTROL STUDIES; CHROMOGRANIN A; CHROMOGRANINS; DIAGNOSIS, DIFFERENTIAL; ENTEROCHROMAFFIN-LIKE CELLS; FEMALE; GASTRITIS, ATROPHIC; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS;

EID: 15944395066     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.01862     Document Type: Article

References (31)

1. Modlin IM, Lye KD & Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? American Journal of Gastroenterology 2004 99 23-32.
2. Hegde V, Mohandas KM, Ramadwar M, Shukla P & Mehta S. Gastric carcinoids - a changing trend. Indian Journal of Gastroenterology 2003 22 209-211.
3. Modlin IM, Lye KD & Kidd M. Carcinoid tumors of the stomach. Surgical Oncology 2003 12 153-172.
4. Annibale B, Azzoni C, Corleto VD, di Giulio E, Caruana P, D'Ambra G, Bordi C & Delle Fave G. Atrophic body gastritis patients with enterochromaffin-like cell dysplasia are at increased risk for the development of type I gastric carcinoid. European Journal of Gastroenterology and Hepatology 2001 13 1449-1456.
5. Chiba T. One more new gastric disease induced by Helicobacter pylori infection, enterochromaffin-like (ECL) cell carcinoid tumor. Journal of Gastroenterology 1999 34 545-546.
6. Sato Y, Iwafuchi M, Ueki J, Yoshimura A, Mochizuki T, Motoyama H, Sugimura K, Honma T, Narisawa R, Ichida T, Asakura H & Van Thiel DH. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Digestive Diseases and Sciences 2002 47 579-585.
7. Creutzfeldt W. The achlorhydria-carcinoid sequence: role of gastrin. Digestion 1988 39 61-79.
8. Bordi C, D'Adda T, Azzoni C, Pilato FP & Caruana P. Hypergastrinemia and gastric enterochromaffin-like cells. American Journal of Surgical Pathology 1995 19 (Suppl 1) S8-S19.
9. Solcia E, Fiocca R, Villani L, Luinetti O & Capella C. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. American Journal of Surgical Pathology 1995 19 (Suppl 1) S1-S7.
10. Deftos LJ. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocrine Reviews 1991 12 181-187.
11. O'Connor DT & Deftos LJ. Secretion of chromogranin A by peptide producing endocrine neoplasms. New England Journal of Medicine 1986 314 1145-1151.
12. Nobels FRE, Kwekkeboom DJ, Boullon R & Lamberts SWJ. Chromogranin A: its clinical value as marker of neuroendocrine tumors. European Journal of Clinical Investigation 1998 28 431-440.
13. Stabile BE, Howard TJ, Passarro E Jr & O'Connor DT. Source of plasma chromogranin A elevation in gastrinoma patients. Archives of Surgery 1990 125 451-453.
14. Burch K, Stridsberg M, Burman P & Rehfeld JF. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scandinavian Journal of Gastroenterology 1997 32 198-202.
15. Grandberg D, Wilander E, Stridsberg M, Granerus G, Skogseid B & Oberg K. Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids. Gut 1998 43 223-228.
16. Baudin E, Gigliotti A, Ducreux M, Ropers J, Comoy E, Sabourin JC, Bidart JM, Cailleux AF, Bonacci R, Ruffie P & Schlumberger M. Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours. British Journal of Cancer 1998 78 1102-1107.
17. Bajetta E, Ferrari L, Martinetti A, Celio L, Procopio G, Artale S, Zilembo N, Di Bartolomeo M, Seregni E & Bombardieri E. Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer 1999 86 858-865.
18. Peracchi M, Conte D, Gebbia C, Penati C, Pizzinelli S, Arosio M, Corbetta S & Spada A. Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1. European Journal of Endocrinology 2003 148 39-43.
19. De Block CE, Colpin G, Thielemans K, Coopmans W, Bogers JJ, Pelckmans PA, Van Marck EA, Van Hoof V, Martin M, De Leeuw IH, Bouillon R & Van Gaal LF. Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes. Diabetes Care 2004 27 1387-1393.
20. Bashir S, Gibril F, Ojeaburu JV, Asgharian B, Entsuah LK, Ferraro G, Crafa P, Bordi C & Jensen RT. Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas. Alimentary Pharmacology and Therapeutics 2002 16 1367-1382.
21. Sanduleanu S, De Bruïne A, Stridsberg M, Jonkers D, Biemond I, Hameeteman W, Lundqvist G & Stockbrügger RW. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. European Journal of Clinical Investigation 2001 31 802-811.
22. Dixon MF, Genta RM, Yardley JH & Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. American Journal of Surgical Pathology 1996 20 1161-1181.
23. Stridsberg M, Eriksson B, Öberg K & Janson ET. A comparison between three commercial kits for chromogranin A measurements. Journal of Endocrinology 2003 177 337-341.
24. Peracchi M, Tagliabue R, Quatrini M & Reschini E. Plasma pancreatic polypeptide response to secretin. European Journal of Endocrinology 1999 141 47-49.
25. Sackett DL & Haynes RB. The architecture of diagnostic research. In The Evidence Base of Clinical Diagnosis, ch 2, pp 19-38. Ed. JA Knottnerus. London: BMJ Books, 2002.
26. Kimura K, Chen D, Lindström E, Zhao CM & Hakanson R. Evidence that rat stomach ECL cells represent the main source of circulating pancreastatin. Regulatory Peptides 1997 68 177-180.
27. Goebel SU, Serrano J, Yu F, Gibril F, Venzon DJ & Jensen RT. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent or growth of gastrinomas. Cancer 1999 85 1470-1483.
28. Dittmar M & Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. Journal of Clinical Endocrinology and Metabolism 2003 88 2983-2992.
29. Selking O, Borch K, Johansson H, Ljunghall S & Wide L. Evaluation of parathyroid function in patients with hypergastrinaemia and pernicious anaemia. Upsala Journal of Medical Sciences 1982 87 215-222.
30. Corleto VD, Minisola S, Moretti A, Damiani C, Grossi C, Ciardi S, D'Ambra G, Bordi C, Strom R, Spagna G, Delle Fave G & Annibale B. Prevalence and causes of hypergastrinemia in primary hyperparathyroidism: a prospective study. Journal of Clinical Endocrinology and Metabolism 1999 84 4554-4558.
31. Corleto VD, Goebel SU, Panzuto F, Jensen RT, Delle Fave G & Annibale B. Co-existence of hyperparathyroidism, hypergastrinaemia and multiple gastric carcinoids is not always due to incomplete expression of the MEN-1 syndrome. Digestive and Liver Disease 2003 35 585-589.